The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer

Carcinogenesis

Volumn 32, Issue 3, 2011, Pages 327-330

  Almquist, Lindsay M ^a,b   Karagas, Margaret R ^c,d   Christensen, Brock C ^e,f   Welsh, Marleen M ^g   Perry, Ann E ^h   Storm, Craig A ^h   Nelson, Heather H ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Dartmouth Medical School ^*  (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e BROWN UNIVERSITY   (United States)

^f BROWN UNIVERSITY   (United States)

^g Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^h DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROLINE; PROTEIN MDM2; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUTAGENESIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA;

EID: 79952291551     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq256     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures (2005). American Cancer Society, Atlanta, GA.
2. Momand,J. et al. (2000) MDM2-master regulator of the p53 tumor suppressor protein. Gene, 242, 15-29.
3. Harris,S.L. et al. (2005) Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc. Natl Acad. Sci. USA, 102, 16297-16302.
4. Thomas,M. et al. (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell. Biol., 19, 1092-1100.
5. Dumont,P. et al. (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet., 33, 357-365.
6. Han,J. et al. (2006) The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women. Mol. Carcinog., 45, 694-700.
7. Chen,Y.C. et al. (2003) Genetic polymorphism in p53 codon 72 and skin cancer in southwestern Taiwan. J. Environ. Sci. Health A Tox Hazard Subst. Environ. Eng., 38, 201-211.
8. Bendesky,A. et al. (2007) p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer. Mutat. Res., 619, 38-44.
9. Marin,M.C. et al. (2000) A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet., 25, 47-54.
10. King,K.E. et al. (2007) p63: defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis. Mol. Carcinog., 46, 716-724.
11. Karagas,M.R. et al. (1999) Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int. J. Cancer, 81, 555-559.
12. Ara,S. et al. (1990) Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res., 18, 4961.
13. Danaee,H. et al. (2006) Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin. J. Invest. Dermatol., 126, 1152-1158.
14. Toguchida,J. et al. (1992) Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N. Engl. J. Med., 326, 1301-1308.
15. Kelsey,K.T. et al. (2005) TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer. Int. J. Cancer, 117, 370-375.
16. Bond,G.L. et al. (2004) A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell, 119, 591-602.
17. Bougeard,G. et al. (2006) Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. J. Med. Genet., 43, 531-533.
18. Wilkening,S. et al. (2007) MDM2 SNP309 and cancer risk: a combined analysis. Carcinogenesis, 28, 2262-2267.
19. Wilkening,S. et al. (2007) No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin. Br. J. Dermatol., 157, 375-377.
20. Nan, H. et al. (2009) A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer. Cancer Causes Control, 20, 171-179.
21. McGregor,J.M. et al. (2002) Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J. Invest. Dermatol., 119, 84-90.
22. Nelson,H.H. et al. (2005) TP53 mutation, allelism and survival in nonsmall cell lung cancer. Carcinogenesis, 26, 1770-1773.
23. Mills,A.A. et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713.
24. Yang,A. et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714-718.